FI20086024A0 - Ny farmaceutisk produkt - Google Patents

Ny farmaceutisk produkt

Info

Publication number
FI20086024A0
FI20086024A0 FI20086024A FI20086024A FI20086024A0 FI 20086024 A0 FI20086024 A0 FI 20086024A0 FI 20086024 A FI20086024 A FI 20086024A FI 20086024 A FI20086024 A FI 20086024A FI 20086024 A0 FI20086024 A0 FI 20086024A0
Authority
FI
Finland
Prior art keywords
pharmaceutical product
new pharmaceutical
new
product
pharmaceutical
Prior art date
Application number
FI20086024A
Other languages
English (en)
Finnish (fi)
Inventor
Raili Myllylae
Heli Ruotsalainen
Original Assignee
Oulun Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oulun Yliopisto filed Critical Oulun Yliopisto
Priority to FI20086024A priority Critical patent/FI20086024A0/sv
Publication of FI20086024A0 publication Critical patent/FI20086024A0/sv
Priority to PCT/FI2009/050869 priority patent/WO2010049590A2/en
Priority to EP09759744A priority patent/EP2349326A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11004—Procollagen-lysine 5-dioxygenase (1.14.11.4), i.e. lysine-hydroxylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
FI20086024A 2008-10-29 2008-10-29 Ny farmaceutisk produkt FI20086024A0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20086024A FI20086024A0 (sv) 2008-10-29 2008-10-29 Ny farmaceutisk produkt
PCT/FI2009/050869 WO2010049590A2 (en) 2008-10-29 2009-10-29 A new pharmaceutical product
EP09759744A EP2349326A2 (en) 2008-10-29 2009-10-29 A new pharmaceutical product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20086024A FI20086024A0 (sv) 2008-10-29 2008-10-29 Ny farmaceutisk produkt

Publications (1)

Publication Number Publication Date
FI20086024A0 true FI20086024A0 (sv) 2008-10-29

Family

ID=39924662

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20086024A FI20086024A0 (sv) 2008-10-29 2008-10-29 Ny farmaceutisk produkt

Country Status (3)

Country Link
EP (1) EP2349326A2 (sv)
FI (1) FI20086024A0 (sv)
WO (1) WO2010049590A2 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140073575A1 (en) * 2011-04-15 2014-03-13 Universitaet Zuerich Prorektorat Mnw Collagen hydroxylases
GB201202561D0 (en) * 2012-02-15 2012-03-28 Univ Dundee Treatment of skin disorders
US20240209029A1 (en) * 2021-04-21 2024-06-27 The University Of Hong Kong Adiponectin glycopeptides and compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034556B2 (en) * 2004-05-28 2011-10-11 The Regents Of The University Of California Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity
WO2007146171A2 (en) * 2006-06-08 2007-12-21 Trustees Of Tufts College Purified high molecular weight adiponectin and uses thereof
WO2009080898A2 (en) * 2007-12-21 2009-07-02 Oulun Yliopisto Products and methods for preventing tumour growth

Also Published As

Publication number Publication date
WO2010049590A3 (en) 2010-06-24
WO2010049590A2 (en) 2010-05-06
EP2349326A2 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
CY2018030I2 (el) Φαρμακοτεχνικη μορφη 514
SMT201700095B (is) Composizioni farmaceutiche per inalazione
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0908130A2 (pt) Produto
DK2151438T3 (da) Lægemiddel indeholdende PPAR-Deltaagonist
BRPI0813753A2 (pt) Produto pré-impregnado
FI20085052A0 (sv) Tobaksprodukt
DK3097925T3 (da) Farmaceutisk sammensætning
ATE531278T1 (de) Süsswaren-produkt
BRPI1004940A2 (pt) composição farmacêutica
SMT201400069B (it) Formulazione farmaceutica
BRPI1015939A2 (pt) composição farmacêutica
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI1016190A2 (pt) compostos farmacêuticos.
FI20085767L (sv) Gipsprodukt
BRPI0921654A2 (pt) formulação farmacêutica
BRPI0921313A2 (pt) composição farmaucêutica
DK2271618T3 (da) Farmaceutiske forbindelser
BR112012003149A2 (pt) composição farmacêutica
BRPI0912171A2 (pt) composição farmacêutica
FI20080348A0 (sv) Ny farmaceutisk formulering
BRPI0921301A2 (pt) composição farmacêutica
FI20086024A0 (sv) Ny farmaceutisk produkt
BRPI0920277A2 (pt) produto
BRPI1008983A2 (pt) formulação farmacêutica

Legal Events

Date Code Title Description
FD Application lapsed